TrialJCI insight2018

T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma.

Alexander C Hopkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.